Sagimet Biosciences Inc. Class A
SGMT · NASDAQ · USD
$8.83
−0.095 −1.07%todayNot financial advice.
- Open
- 8.84
- Day range
- 8.78 - 8.85
- 52-week range
- 4.50 - 11.45
- Volume
- 22.8K
- Market cap
- 620.76M
- P/E ratio
- —
- EPS
- -1.28
- Dividend yield
- 0.00%
- Beta
- 2.66
Performance
W
−4.70%
1M
−21.56%
3M
+19.58%
6M
+56.75%
YTD
+46.84%
Y
+18.62%
5Y
−43.06%
All
−43.06%
In the news
Oct 9
Sagimet Biosciences Announces Positive 52-Week Acne Trial Data And U.S. Phase 3 Launch
Sagimet Biosciences announced positive 52-week data for its acne drug denifanstat and is starting screening for its U.S. Phase 3 clinical trial.
Company news
Oct 9
Sagimet Biosciences Reports Positive Long-Term Phase 3 Acne Trial Data
Sagimet Biosciences announced positive 52-week data for its acne drug denifanstat as it prepares to launch a U.S. Phase 3 study.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-SGMT" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Sagimet Biosciences Inc. Class A (SGMT) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-SGMT">SGMT stock price</a> by FreeTheAI Stocks</p>